Tarsus Pharmaceuticals Inc

NASDAQ:TARS  
15.95
-0.08 (-0.50%)
Products

Tarsus Submits New Drug Application To The FDA For Tp-03 For The Treatment Of Demodex Blepharitis

Published: 09/07/2022 11:16 GMT
Tarsus Pharmaceuticals Inc (TARS) - Tarsus Submits New Drug Application to the FDA for Tp-03 for the Treatment of Demodex Blepharitis.